Your family means the world to you, and we're here to help you protect it. Through our sister company, Cord Blood Registry (CBR), all NW Cryobank families now receive the special perks of cord blood and cord tissue banking. This is provided at no additional cost through the Cord Blood Advantage Program, a $2,860 value.
Since cord blood and cord tissue stem cells function differently, they may help repair the body in different ways.
Cord blood is the blood that remains in the umbilical cord and placenta after delivery.
Umbilical cord blood contains hematopoietic stem cells (HSCs), which have a 30-year history of saving lives. These powerful stem cells are the building blocks of the blood and immune system, and are used in the treatment of over 80 diseases like:
- Blood disorders
- Certain cancers
- Immune disorders
- Metabolic disorders
Cord blood is the blood that remains in the umbilical cord and placenta after delivery.
Umbilical cord blood contains hematopoietic stem cells (HSCs), which have a 30-year history of saving lives. These powerful stem cells are the building blocks of the blood and immune system, and are used in the treatment of over 80 diseases like:
Cord tissue is in your baby's umbilical cord, which contains mesenchymal stem cells.
Umbilical cord tissue is home to several cell types, including mesenchymal stem cells (MSCs). MSCs are among the most widely researched cell types in the field of regenerative medicine.1 Currently they're being researched for conditions in categories like:
- Autoimmune
- Orthopedic
- Cardiovascular
- Neurological (acquired & degenerative)
Cord tissue is in your baby's umbilical cord, which contains mesenchymal stem cells.
Umbilical cord tissue is home to several cell types, including mesenchymal stem cells (MSCs). MSCs are among the most widely researched cell types in the field of regenerative medicine.1 Currently they're being researched for conditions in categories like:
References: 1. Saleh R, Reza HM. Short review on human umbilical cord lining epithelial cells and their potential clinical applications. Stem Cell Res Ther. 2017;8(1):222. Published 2017 Oct 10. doi: 10.1186/s13287-017-0679-y 2. Munoz J, Shah N, Rezvani K, et al. Concise review: umbilical cord blood transplantation: past, present, and future. Stem Cells Transl Med. 2014;3:1435-1443. 3. Gluckman E, Rocha V, Boyer-Chammard A, et al.; for Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 1997;337:373-381. http://www.ncbi.nlm.nih.gov/pubmed/92411266 4. www.clinicaltrials.gov
*Annual storage rates subject to change
The use of cord blood is determined by the treating physician and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the cord blood should come from the patient or an appropriately matched donor. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available.
Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Cbr Systems, Inc.’s activities for New York State residents are limited to collection of umbilical cord tissue and long-term storage of umbilical cord–derived stem cells. Cbr Systems, Inc.’s possession of a New York State license for such collection and long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.
Copyright © 1995 - 2020 CBR Systems, Inc. All rights reserved.